Related Experiment Video
Updated: May 2, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.2K
Prescribing for acute childhood infections in developing and transitional countries, 1990-2009
Paediatrics and International Child Health
|March 14, 2014
Summary
Global progress in treating acute paediatric infections is limited. While diarrhoea treatment improved, malaria and respiratory infections remain sub-optimal, highlighting the need for better interventions.
Area of Science:
- Global Health
- Paediatric Infectious Diseases
- Health Services Research
Background:
- Evidence on global progress in treating acute paediatric infections is scarce.
- Childhood infections remain a significant global health challenge, particularly in developing and transitional countries.
Purpose of the Study:
- To assess two decades of progress in prescribing practices for childhood infections.
- To review empirical evidence on interventions aimed at improving the treatment of paediatric infections in developing and transitional countries.
Main Methods:
- Systematic extraction of data on medicine use for diarrhoea, respiratory infections, and malaria in children under 5 (1990-2009).
- Calculation of medians across studies based on year, region, sector, income level, and prescriber type.
- Estimation of intervention effects using methodologically accepted study designs (RCTs, pre-post with control, time series).
Main Results:
- Analysis of 344 studies from 78 countries; 44 intervention studies with adequate designs were used for effect estimation.
- Significant decrease in anti-diarrhoeal use for acute diarrhoea (P<0.01), but sub-optimal treatment for malaria and acute respiratory infections.
- Multi-component interventions showed greater improvement (e.g., community case-management: 28% improvement) than single-component ones (e.g., provider education alone: 9% improvement).
Conclusions:
- Diarrhoea treatment in children has improved over 20 years, but treatment for other common childhood infections remains suboptimal.
- Multi-component interventions show promise for improving the management of acute childhood illnesses.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410

